These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26833153)

  • 21. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
    Dosler S; Karaaslan E
    Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
    Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
    J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.
    Torres BGS; Helfer VE; Bernardes PM; Macedo AJ; Nielsen EI; Friberg LE; Dalla Costa T
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
    Elkhatib W; Noreddin A
    Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing
    Müsken M; Pawar V; Schwebs T; Bähre H; Felgner S; Weiss S; Häussler S
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
    Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
    PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of host-mimicking medium and biofilm growth on the ability of colistin to kill
    Sweeney E; Sabnis A; Edwards AM; Harrison F
    Microbiology (Reading); 2020 Dec; 166(12):1171-1180. PubMed ID: 33253080
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellulose Nanofibril Formulations Incorporating a Low-Molecular-Weight Alginate Oligosaccharide Modify Bacterial Biofilm Development.
    Jack AA; Nordli HR; Powell LC; Farnell DJJ; Pukstad B; Rye PD; Thomas DW; Chinga-Carrasco G; Hill KE
    Biomacromolecules; 2019 Aug; 20(8):2953-2961. PubMed ID: 31251598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted disruption of the extracellular polymeric network of
    Powell LC; Pritchard MF; Ferguson EL; Powell KA; Patel SU; Rye PD; Sakellakou SM; Buurma NJ; Brilliant CD; Copping JM; Menzies GE; Lewis PD; Hill KE; Thomas DW
    NPJ Biofilms Microbiomes; 2018; 4():13. PubMed ID: 29977590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound model.
    Laulund ASB; Trøstrup H; Lerche CJ; Thomsen K; Christophersen L; Calum H; Høiby N; Moser C
    Pathog Dis; 2020 Jul; 78(5):. PubMed ID: 31116394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nanoscale characterization of the interaction of a novel alginate oligomer with the cell surface and motility of Pseudomonas aeruginosa.
    Powell LC; Pritchard MF; Emanuel C; Onsøyen E; Rye PD; Wright CJ; Hill KE; Thomas DW
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):483-92. PubMed ID: 24074505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.
    Loo CY; Lee WH; Lauretani G; Scalia S; Cipolla D; Traini D; Young P; Ong HX
    Pharm Res; 2018 Feb; 35(3):50. PubMed ID: 29417313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic lung infection by Pseudomonas aeruginosa biofilm is cured by L-Methionine in combination with antibiotic therapy.
    Gnanadhas DP; Elango M; Datey A; Chakravortty D
    Sci Rep; 2015 Nov; 5():16043. PubMed ID: 26521707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biofilm formation by Pseudomonas aeruginosa in solid murine tumors - a novel model system.
    Komor U; Bielecki P; Loessner H; Rohde M; Wolf K; Westphal K; Weiss S; Häussler S
    Microbes Infect; 2012 Sep; 14(11):951-8. PubMed ID: 22542841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
    García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R
    Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
    Cai Y; Wang R; Liang BB; An MM
    J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.